Study of Adjuvant ONO-4538 With Resected Gastric Cancer

NCT03006705 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Nivolumab
DRUG: Tegafur-gimeracil-oteracil potassium
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Placebo

Sponsor

Ono Pharmaceutical Co., Ltd.

Collaborators

[object Object]